Graduated from the School of Medicine, Tokyo Jikeikai. Passed the Japanese National Examinations for Medical Practitioners. M.D. at the School of Medicine, Keio University. Professor at the Cancer Research Institute of Columbia University, Professor at the School of Medicine, Tokyo Jikeikai University, visiting Professor at Harbored University, First President of the DNA Medical Institute at Jikei University and Honorary Professor at Tokyo Jikeikai School of Medicine. Chairman of the Board of Directors of the Medical Corporation Jiyukai.
Graduated from Tohoku University, Faculty of Science. PhD at The University of Pennsylvania. Researcher at Wister Institute, The University of Pennsylvania, Biochemistry Assistant at McGill University, Researcher at the Endocrinology Institute, Hamburg University, School of Medicine, Director at Cellular Engineering Center of Meiji Milk Products Co., Ltd., President of Bio Venture Company (Cell Signals Co., Ltd.). Specialist in Biochemistry. Appointed as Executive Director of the company in September 2010. Appointed as the President & CEO from September 2011 through June 2016. Current chairman of the company.
Graduated from the School of Medicine, Gifu University. Passed the Japanese National Examinations for Medical Practitioners. Intern at Sapporo Medical School (Major in Pathology). Researcher at School of Medicine at Stanford University. Doctor of Medicine. Director of Clinical Studies and subsequently a special assistant to Chair of the Board of Directors at National Children’s Medical Research Center (Currently National Center for Child Health and Development). Board of Directors of the Medical Corporation Jiyukai. President of Acti-clinic.